Dermira

Acquired

Bringing biotech ingenuity to medical dermatology

Menlo Park, United States · Founded 2010 · $202.0M raised

Employees
201–500
Founded
2010
Business Model
B2B
Total Funding
$202.0M
Last Round
$125.0M Venture RoundOct 2014
Rounds
5
Acquisition Date
Jan 2020

About

Dermira was a specialty biopharmaceutical company dedicated to developing differentiated therapies for chronic skin conditions. Based in Menlo Park, California, Dermira developed lebrikizumab (an IL-13 antibody for atopic dermatitis) and Qbrexza (for hyperhidrosis). The company was acquired by Eli Lilly for approximately $1.1 billion in 2020.

Summary

Dermira is a Biotech company based in Menlo Park, United States, founded in 2010. It has raised $202.0M in total across 5 rounds, most recently a $125.0M Venture Round round in Oct 2014. Investors include Bay City Capital, Eli Lilly and Maruho Co., Ltd..

Funding History

AcquisitionAcquisition by Eli LillyJan 2020

Sign up to see all 6 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dermira on Indexed.vc
<a href="https://indexed.vc/companies/dermira"><img src="https://indexed.vc/api/badge/company/dermira" alt="Dermira on Indexed.vc" width="260" height="76" /></a>